Search Results 31-40 of 13382 for lewy body dementia
This common dementia is caused by a buildup of proteins in the brain. It affects thinking, memory and movement.
Also, to test the hypothesis that prospective intervention with a DPP4 inhibitor or SGLT2 inhibitor improves Parkinson's disease and Lewy Body Dementia related ...
... Lewy body dementia. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder · Overview · Participation eligibility.
Dementia with Lewy bodies (DLB) is part of Lewy body dementia, the 2nd-most-common degenerative dementia in the U.S. It is also one of the Alzheimer's ...
The purpose of this study is to examine the effects of the medication Armodafinil in patients who have dementia with Lewy bodies which is associated with ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Benefactor support fuels Mayo Clinic’s groundbreaking research. Make a gift today to help us save lives.